SCHEMBL4461767

SCHEMBL4461767

Cn1c(=O)c2c(ncn2CCN2CCN(Cc3ccccc3)CC2)n(C)c1=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.73
SMN1; SMN2 Q16637 2/20 0.73
RXFP1 Q9HBX9 1/20 0.73
ALDH1A1 P00352 5/20 0.68
TSHR P16473 2/20 0.65
HTR7 P34969 1/20 0.64
HTR6 P50406 1/20 0.64
ALOX15 P16050 1/20 0.60
HSD17B10 Q99714 1/20 0.60
HTT P42858 3/20 0.59
GLA P06280 1/20 0.58
UBE2N P61088 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
LMNA P02545 1/20 0.58
MAPK1 P28482 1/20 0.58
MAPT P10636 1/20 0.57
USP2 O75604 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
POLB P06746 1/20 0.57
HIF1A Q16665 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683634 0.90 HTR7 (0.67) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL4460765 0.86 PDE1A (0.77) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL1810048 0.86 HTR7 (0.84) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL1944405 0.85 ADORA2B (1.00) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL684000 0.85 SMN1; SMN2 (0.65) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL14754378 0.85 L3MBTL1 (0.74) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL458792 0.83 HTR7 (0.63) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL29375465 0.83 HTR7 (0.63) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL4458227 0.82 HTR7 (0.59) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
Hydrochloric Acid SCHEMBL2290149 0.82 HTR7 (0.65) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550468-B2 Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase CHEN ING-JUN 2009-06-23 US disclosed
US-20050209242-A1 Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase CHEN ING-JUN 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209242-A1 Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase PDE3A, PDE5A, PDE3B ADORA2B 156/4885SMN1; SMN2 2678/4885RXFP1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.